Life Sciences

Biotechnology, pharmaceutical, healthcare and medical device companies put innovation at the centre of their business life, yet they operate within a strict legal and regulatory framework. The inherent risks surrounding product development and usage and business strategy, call for legal advice that is more than technically excellent.

Our Life Sciences Team includes numerous practitioners who are tertiary qualified in health and science with experience in biotechnology research, giving us exceptional understanding of the unique legal challenges facing this sector.

Our responsive advice assists clients with safeguarding their businesses, innovations and strategies, and to promote and foster efficiency and effectiveness in their organisations. We regularly assist with assessing, monitoring and managing legal risk, and also advise on a significant variety of commercial issues.

Our expertise includes advising in relation to research and development arrangements, protection and commercialisation of intellectual property, government funding, probity, clinical trials, corporate advice including capital raisings and mergers and acquisitions, commercial arrangements, information technology, privacy, product regulation and liability matters.

Our clients include universities and research institutes, medical device, pharmaceutical and complementary medicine organisations, health and allied health providers (including pathology and radiology practices, hospitals and nursing homes) and health care insurers.

The Legal 500 Life Sciences Comparative Guide 2024 – Australia

The inaugural edition of the Legal 500 Life Sciences Comparative Guide examines the current challenges facing organisations operating in the life sciences sector within specific countries. Gadens has contributed the Australian chapter for this global guide, setting out a helpful roadmap for life sciences companies, researchers and healthcare professionals to navigate legal and regulatory compliance in Australia.

See our full chapter here: The Legal 500 Life Sciences Comparative Guide 2024 – Australia | Gadens